Skip Navigation


Glycobiology Advance Access originally published online on February 26, 2008
Glycobiology 2008 18(5):408-413; doi:10.1093/glycob/cwn017
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
18/5/408    most recent
cwn017v2
cwn017v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Miyamoto, K.
Right arrow Articles by Kusunoki, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyamoto, K.
Right arrow Articles by Kusunoki, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Roles of complex gangliosides in the development of experimental autoimmune encephalomyelitis

Katsuichi Miyamoto2, Kazuo Takada2, Keiko Furukawa3, Koichi Furukawa3 and Susumu Kusunoki1,2

2 Department of Neurology, Kinki University School of Medicine, Osaka
3 Department of Biochemistry, Nagoya University School of Medicine, Nagoya, Japan


1 To whom correspondence should be addressed: Tel: +81-72-366-0221; Fax: +81-72-368-4846; e-mail: kusunoki-tky{at}umin.ac.jp

Received on September 11, 2007; revised on December 28, 2007; accepted on February 20, 2008

We induced experimental autoimmune encephalomyelitis (EAE) in GM2/GD2 synthase knockout mice (GM2/GD2–/–), which cannot synthesize complex gangliosides, such as GM1, GD1a, GD1b, GT1b, and GQ1b, to investigate the roles of complex gangliosides in the pathogenesis of this disease. We used myelin-oligodendrocyte glycoprotein (MOG) as an immunogen. In active immunization EAE, the severity of clinical score was not different but the disease onset was significantly delayed in GM2/GD2–/– compared with those in wild-type mice. When we transferred MOG-reactive T cells from GM2/GD2–/– or wild-type mice to wild-type mice, no significant differences were observed between the two groups. In contrast, when we transferred MOG-reactive T cells from wild-type mice to GM2/GD2–/– or to wild-type mice, the onset of EAE in GM2/GD2–/– mice was delayed. The recall response of MOG-specific T cells, the function of antigen presenting cells, or the expression of several adhesion molecules in the endothelium were not significantly different between GM2/GD2–/– and wild-type mice. On the other hand, quantitative analysis of cellular infiltration in the central nervous system (CNS) on day 9 of active immunization EAE showed that the CD4+ cell number in the CNS isolated from GM2/GD2–/– mice was significantly less than that from wild-type mice. It indicated that the delayed onset of EAE in GM2/GD2–/– mice was due to the delay of the migration of pathogenic T cells into the CNS. Thus, the complex gangliosides may be involved in the T cell–endothelial cell interaction in the pathogenetic process of EAE.

Key words: EAE / MS / neuroimmunology / rodent / cell surface molecules


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.